Stocks
AbbVie (ABBV) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 48.9% | 46.2% | 50.3% | 54.1% | 48.5% | 45.9% | ||
| Changes by years, y/y, % | +24pp | -3pp | +4pp | +4pp | -6pp | +14.3% | |||
AbbVie. EBITDA margin, %
AbbVie. EBITDA margin, changes, pp
AbbVie (ABBV) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q4 | 2024Q1 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | 46.3% | 45.7% | 45.1% | 49.3% | 43.3% | 45.9% | |
| Changes by years, y/y, % | -4pp | +6pp | +5pp | +0pp | +10pp | |||
| Changes by quarters, q/q, % | +13pp | -1pp | -1pp | +4pp | -6pp | |||
